Adult Dosing

Acute, painful musculoskeletal conditions

• 250-350 mg PO tid and at bedtime
• Max duration: 2-3 wks

Pediatric Dosing

• Safety and efficacy not established in children < 16 yrs of age

Acute, painful musculoskeletal conditions (Not FDA approved)

Child > 16 yrs

• 250-350 mg PO tid and at bedtime
• Max duration: 2-3 wks

• Adjunctive therapy in the treatment of muscle spasm associated with acute painful musculoskeletal conditions. Should only be used for acute treatment periods for up to two or three weeks

• Hypersensitivity to any of the ingredient of the product
• Acute intermittent porphyria
• Suspected porphyria
• Hypersensitivity to felbamate
• Hypersensitivity to meprobamate

• N/A

Renal Dose Adjustment

• Renail impairment: Dose adjustments not defined

Hepatic Dose Adjustment

• Hepatic impairment: Use with caution

• Carisoprodol has sedative properties. It may impair mental and physical abilities required for performance of potentially hazardous tasks such as driving a motor vehicle or operating machinery
• Cases of dependence, withdrawal, and abuse have been reported with prolonged use. Do not withdraw abruptly. Use w/ caution in addiction prone patients and in patients taking other CNS depressants
• Monitor for the signs of idiosyncratic reactions. These reactions may appear within minutes or hours of first dose. Symptoms usually subside over several hours. If such reactions occur, withhold drug

Cautions: Use cautiously in

• Renal impairment
• Hepatic impairment
• Seizure disorder
• Hx of seizure disorder
• Hx of substance abuse
• Concomitant CNS depressants
• Geriatric population
• Debilitated patients

Pregnancy Category:C

Breastfeeding: Excreted in breast milk. Slight sedation may occur in breastfed newborn infants. Sedation might be more pronounced in newborns who are exposed for the first time during nursing. Other agents may be preferred, especially while nursing a newborn or preterm infant, or if other sedation causing drugs are used simultaneously. This information is based upon LactMed database (available at http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT last accessed 11 May 2010).

• CNS: Drowsiness, dizziness, headache; vertigo, agitation, irritability, ataxia, tremor, depression, syncope, insomnia, seizures (post marketing)
• CV: Tachycardia, postural hypotension, facial flushing (post marketing)
• GI: Epigastric discomfort, nausea, vomiting (post marketing)
• HEMA: Leukopenia, pancytopenia (post marketing)
• DERM: Erythema multiforme
• MISC: Dependency, abuse, withdrawl if abrupt cessation, angioneurotic edema, anaphylactoid shock

• Centrally acting skeletal muscle relaxant; Mechanism of action: Centrally-acting muscle relaxant
• Metabolized by liver to active metabolite meprobamate; CYP450: 2C19 substrate
• Primarily renally excreted (< 1% unchanged)
• Half-life: 2 hrs (parent drug); 10 hrs (meprobamate)

US Trade Name(s)

• Soma

US Availability

carisoprodol

• TABS: 350 mg

Soma

• TABS: 250, 350 mg

Canadian Trade Name(s)

• N/A

Canadian Availability

• N/A

UK Trade Name(s)

• N/A

UK Availability

• N/A

Australian Trade Name(s)

• N/A

Australian Availability

• N/A

Analgesics

Skeletal Muscle Relaxants

Pricing data from www.DrugStore.com in U.S.A.

• Soma 250 MG TABS [Bottle] (MEDA PHARMACEUTICALS)
  100 mg = $399
  300 mg = $1155.94
• Carisoprodol 350 MG TABS [Bottle] (QUALITEST)
  30 mg = $14.99
  90 mg = $35.97
• Soma 350 MG TABS [Bottle] (MEDA PHARMACEUTICALS)
  30 mg = $205.99
  90 mg = $560.94

Warning: This pricing information is subject to change at the sole discretion of DS Pharmacy. For the most current and up-to-date pricing information, please visit drugstore.com.

• CARISOPRODOL 250 mg (Wallace Pharmaceuticals Inc.)
• Carisoprodol 350 MG Oral Tablet (4UORTHO LLC)
• Carisoprodol 350 MG Oral Tablet (Actavis Totowa LLC)
• Carisoprodol 350 MG Oral Tablet (Altura Pharmaceuticals, Inc.)
• Carisoprodol 350 MG Oral Tablet (American Health Packaging)
• Carisoprodol 350 MG Oral Tablet (Apotheca, Inc.)
• Carisoprodol 350 MG Oral Tablet (Aurobindo Pharma Limited)
• Carisoprodol 350 MG Oral Tablet (COREPHARMA LLC.)
• Carisoprodol 350 MG Oral Tablet (Mutual Pharmaceutical)
• Carisoprodol 350 MG Oral Tablet (Physicians Total Care, Inc.)
• Carisoprodol 350 MG Oral Tablet (Qualitest Pharmaceuticals)
• Carisoprodol 350 MG Oral Tablet (Rebel Distributors Corp.)
• Carisoprodol 350 MG Oral Tablet (Sun Pharmaceutical Industries Limited)
• Carisoprodol 350 MG Oral Tablet (Watson Laboratories, Inc.)
• Carisoprodol 350 MG Oral Tablet (West-ward Pharmaceutical Corp)
• Soma 250 MG Oral Tablet (Meda Pharmaceuticals Inc.)
• Soma 350 MG Oral Tablet (Keltman Pharmaceuticals Inc.)
• Soma 350 MG Oral Tablet (Meda Pharmaceuticals Inc.)